|
|
| Research article summary (published 29 Sep 2009): |
Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
Full Abstract
OBJECTIVE: To investigate the effect of intrauterine selective serotonin reuptake inhibitor (SSRI) exposure on pregnancy outcomes. DESIGN: Prospective cohort study. SETTING: Department of Obstetrics, Aarhus University Hospital, Aarhus, Denmark. PARTICIPANTS: Pregnant women receiving prenatal care in our hospital from 1989 to 2006. MAIN EXPOSURE: Maternal SSRI use during pregnancy. OUTCOME MEASURES: Gestational age, birth weight, head circumference, 5-minute Apgar score, and admission to the neonatal intensive care unit. RESULTS: Three hundred twenty-nine pregnant women reported treatment with SSRIs, 4902 were not treated with SSRIs but had a history of psychiatric illness, and 51 770 reported no history of psychiatric illness. Gestational age was 5 days (95% confidence interval [CI], -6 to -3) shorter and the odds ratio (OR) for preterm birth was 2.0 (95% CI, 1.3-3.2) in the women exposed to SSRIs compared with women with no history of psychiatric illness. In utero-exposed newborns had increased risk of admission to the neonatal intensive care unit (OR, 2.4; 95% CI, 1.7-3.4) and of 5-minute Apgar scores of less than 8 (OR, 4.4; 95% CI, 2.6-7.6) compared with those not exposed. Head circumference and birth weight did not differ between infants in the exposed and unexposed groups. The results were similar when compared with infants of women with a psychiatric history. CONCLUSIONS: Exposure to SSRIs during pregnancy was associated with an increased risk of preterm delivery, a low 5-minute Apgar score, and neonatal intensive care unit admission, which was not explained by lower Apgar scores or gestational age. The study justifies increased awareness to the possible effects of intrauterine exposure to antidepressants.
Author information
Author/s: Lund, Najaaraq (N); Pedersen, Lars H (LH); Henriksen, Tine Brink (TB);
Affiliation: Bandim Health Project, Indepth Network, Apartado 861, Bissau, Guinea-Bissau. najaaraq.lund(-atsign-)gmail.com
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Archives of pediatrics & adolescent medicine (Arch Pediatr Adolesc Med), published in United States. (Language: eng)
Reference: 2009-Oct; vol 163 (issue 10) : pp 949-54
Dates: Created 2009/10/06; Completed 2009/10/26;
PMID: 19805715, status: MEDLINE (last retrieval date: 10/26/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Serotonin reuptake inhibitor-induced perinatal complications.
30 Dec 2006 - Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors.
15 Jun 1998 - Managing depression in primary care.
7 Apr 2005 - Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
27 Feb 2003 - Depression, antidepressants, and sexual function.
30 Jul 1995 - Youth suicide trends place SSRIs in spotlight.
30 Jan 2004 - How have the SSRI antidepressants affected suicide risk?
15 Jun 2006 - SSRIs, suicide and violent behavior: is there a need for a better definition of the depressive state?
30 Dec 2005 - Antidepressants and suicide: rising prescription rate does not mean rising rate of new users.
19 Aug 2004 - Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.
17 Feb 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.